同位素
同位素
동위소
ISOTOPES
2001年
2期
126-128,125
,共4页
HA(透明质酸)%SCG(甘胆酸)%放射免疫检测(RIA)%慢性肝病
HA(透明質痠)%SCG(甘膽痠)%放射免疫檢測(RIA)%慢性肝病
HA(투명질산)%SCG(감담산)%방사면역검측(RIA)%만성간병
采用RIA法对150例肝病患者进行血清HA(透明质酸)和SCG(甘胆酸)含量的测定。结果表明：慢性肝病患者血清中HA和SCG的含量显著高于对照组（P<0.01），与肝功其它指标和肝脏的损伤程度密切相关。提示对血清进行HA和SCG检测及其与常规肝功联合检测是目前对慢性肝病鉴别诊断的理想指标。
採用RIA法對150例肝病患者進行血清HA(透明質痠)和SCG(甘膽痠)含量的測定。結果錶明：慢性肝病患者血清中HA和SCG的含量顯著高于對照組（P<0.01），與肝功其它指標和肝髒的損傷程度密切相關。提示對血清進行HA和SCG檢測及其與常規肝功聯閤檢測是目前對慢性肝病鑒彆診斷的理想指標。
채용RIA법대150례간병환자진행혈청HA(투명질산)화SCG(감담산)함량적측정。결과표명：만성간병환자혈청중HA화SCG적함량현저고우대조조（P<0.01），여간공기타지표화간장적손상정도밀절상관。제시대혈청진행HA화SCG검측급기여상규간공연합검측시목전대만성간병감별진단적이상지표。
The content of serum HA and SCG is determined by RIA in 150 patients of chronic liver diseases.The results show that the content of serum HA and SCG in the patients of chronic liver diseases is evidently higher than that of the comparison team (P<0.01), and closely related to the other targets of liver function and the degree of the liver damage. It suggests that the test of serum HA and SCG and their combined test are the ideal targets for discriminating and diagnosing chronic liver diseases.
